Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,681.00
Bid: 1,686.00
Ask: 1,687.00
Change: -27.00 (-1.58%)
Spread: 1.00 (0.059%)
Open: 1,708.00
High: 1,709.00
Low: 1,679.00
Prev. Close: 1,708.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Smiths Group plc - John Crane Capital Markets Day

17 Dec 2013 07:00

RNS Number : 6930V
Smiths Group PLC
17 December 2013
 



 

News Release

London, 17 December 2013

For immediate release

 

 

Smiths Group plc - JOHN CRANE CAPITAL MARKETS Day

 

Smiths Group plc is today holding a capital markets day in Dubai hosted by its John Crane business.

 

The presentation outlines the division's strategy, business model, markets and describes the growth opportunities and value drivers. As the market leader in mechanical seals and with around 65% of revenues from the energy sector, John Crane is well placed to grow and support top quartile margins while increasing investment in growth opportunities. The presentation will set out operating ranges for mid-single digit organic revenue growth (4-6%) over the medium-term and an expansion in headline operating margins within a range of 22-25%, reflecting the increased growth investment. The growth rate is expected to improve over time as the initiatives gain traction, assuming no discontinuities in the market growth drivers.

 

John Crane will also provide details of its contribution to the Group's 'Fuel for Growth' programme announced in the full year results in September. This further phase of Group-wide restructuring opportunities will generate an estimated £50m of annualised savings at the end of four years for reinvestment in growth initiatives and is expected to cost £100m. John Crane is expected to generate £14m of the total £50m savings at a cost of £28m; these savings will be reinvested for growth. Details of the rest of the programme will be provided at the interim results in March.

 

There will be no update on current trading beyond the Interim Management Statement issued on 19 November 2013.

 

The day will also include a tour of Smiths Detection equipment at Dubai International Airport.

 

The presentation materials will be available on www.smiths.com from 07.00 am (UK time) today. Webcasts and transcripts of the presentations will be posted on the website as soon as they are available after the event has concluded.

 

 

ENDS

 

 

 

Investor Relations

Peter Durman

+44 (0)20 7808 5535

+44 (0) 7825 145336

 

Media

Colin McSeveny

+44 (0)20 7808 5534

 

Anthony Cardew - Cardew Group

+44 (0)20 7930 0777

 

 

Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs more than 23,000 people in over 50 countries. For more information visit www.smiths.com John Crane www.johncrane.com is a world-leading provider of engineered products and services for the major process industries, including oil and gas, power, chemical, pharmaceutical, and other general industries.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBDLBFXLFEFBL
Date   Source Headline
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20243:35 pmRNSTotal Voting Rights
3rd Jun 202410:00 amRNSDirectorate Change
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSSmiths Group 3rd Quarter Results
16th May 20249:30 amRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20244:45 pmRNSDirector/PDMR Shareholding
1st May 20243:30 pmRNSTotal Voting Rights
1st May 202410:00 amRNSBlock listing Interim Review
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:00 amRNSDirector/PDMR Shareholding
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20244:30 pmRNSTotal Voting Rights
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:15 amRNSShare buyback programme
26th Mar 20247:01 amRNSSmiths Group half year results
26th Mar 20247:00 amRNSDirectorate Change
1st Mar 20247:00 amRNSSmiths sells 830,000 shares in ICU Medical Inc
29th Feb 20249:00 amRNSDirectors' Change in Responsibilities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.